Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Red blood cell deformability monitoring in sickle cell disease during treatment initiation
NL-OMON54704Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hydroxyurea in sickle cell disease (SCD) and sickle beta-thalassemia (5 cohorts), sponsored by University Medical Center Utrecht. Started Nov 2017; status: recruiting.
02
Drugs
hydroxyurea
03
Conditions
sickle cell disease (SCD)sickle beta-thalassemia
Beyond the preview
Go deeper on NL-OMON54704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54704.